Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Netherlands
  4. Euronext Amsterdam
  5. Royal DSM N.V.
  6. News
  7. Summary
    DSM   NL0000009827

ROYAL DSM N.V.

(DSM)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Royal DSM N : Koninklijke DSM N.V., - DSM acquires next-generation eubiotics platform start-up

07/27/2021 | 04:00am EDT

Forward-looking statements

This press release may contain forward-looking statements with respect to DSM's future (financial) performance and position. Such statements are based on current expectations, estimates and projections of DSM and information currently available to the company. DSM cautions readers that such statements involve certain risks and uncertainties that are difficult to predict and therefore it should be understood that many factors can cause actual performance and position to differ materially from these statements. DSM has no obligation to update the statements contained in this press release, unless required by law. The English language version of the press release is leading.

Page 2 of 2

DSM acquires next-generation eubiotics platform start-up

Disclaimer

Koninklijke DSM NV published this content on 27 July 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 27 July 2021 07:59:02 UTC.


© Publicnow 2021
All news about ROYAL DSM N.V.
09/14DSM Starts A Review of Strategic Options
CI
09/14ROYAL DSM N : Koninklijke DSM N.V., - DSM accelerates its strategic journey to a..
PU
09/14Europe ends flat as miners, luxury stocks weigh; inflation optimism cools
RE
09/14ROYAL DSM N : Koninklijke DSM N.V., - DSM announces food system commitments to s..
PU
09/14ROYAL DSM N : DSM prefers direct sale of materials division, CEO says
RE
09/14ROYAL DSM N : Dutch DSM to exit materials to focus on food, health and climate
RE
09/14ROYAL DSM N : DSM Begins Strategic Review of Materials Businesses in Health-Focu..
MT
09/14ROYAL DSM N : DSM Targets Livestock Emission Cuts In Set of Food System Commitme..
MT
09/14ROYAL DSM N : DSM announces food system commitments to set a healthier future fo..
PU
09/14ROYAL DSM N : DSM accelerates its strategic journey to a fully focused Health, N..
PU
More news
Analyst Recommendations on ROYAL DSM N.V.
More recommendations
Financials
Sales 2021 8 958 M 10 531 M 10 531 M
Net income 2021 1 500 M 1 763 M 1 763 M
Net Debt 2021 1 097 M 1 290 M 1 290 M
P/E ratio 2021 21,2x
Yield 2021 1,37%
Capitalization 31 868 M 37 492 M 37 464 M
EV / Sales 2021 3,68x
EV / Sales 2022 3,47x
Nbr of Employees 21 173
Free-Float 91,1%
Chart ROYAL DSM N.V.
Duration : Period :
Royal DSM N.V. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ROYAL DSM N.V.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 25
Last Close Price 185,20 €
Average target price 178,47 €
Spread / Average Target -3,63%
EPS Revisions
Managers and Directors
Dimitri de Vreeze Co-Chief Executive Officer & COO
Géraldine Matchett Co-Chief Executive Officer & CFO
Thomas Leysen Chairman-Supervisory Board
Eileen A. Kennedy Member-Supervisory Board
Pradeep Pant Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
ROYAL DSM N.V.31.53%37 378
SHIN-ETSU CHEMICAL CO., LTD.16.71%80 248
BASF SE0.14%70 346
DUPONT DE NEMOURS, INC.-1.55%36 619
PIDILITE INDUSTRIES LIMITED36.11%16 588
ASAHI KASEI CORPORATION19.39%15 899